Vertex Pharmaceutic (VRTX)

Jan 14, 2025, 2:47 PM EST - 3 days ago

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Jan 13, 2025, 12:16 PM EST - 4 days ago

Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 12, 2025, 5:01 PM EST - 5 days ago

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Jan 10, 2025, 7:30 AM EST - 7 days ago

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

ZLAB

Jan 10, 2025, 7:30 AM EST - 7 days ago

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

ZLAB

Jan 7, 2025, 12:23 PM EST - 10 days ago

Vertex Grapples With Bearish Chart As Death Cross Emerges

Jan 7, 2025, 7:00 AM EST - 10 days ago

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

Dec 31, 2024, 9:02 AM EST - 17 days ago

Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested

Dec 23, 2024, 4:05 PM EST - 25 days ago

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

Dec 23, 2024, 3:45 PM EST - 25 days ago

Pharma has value names, but it's not a top pick for 2025, says BMO's Evan Siegerman

BIIB LLY

Dec 23, 2024, 11:13 AM EST - 25 days ago

Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst

Dec 20, 2024, 4:01 PM EST - 4 weeks ago

US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment

Dec 20, 2024, 3:46 PM EST - 4 weeks ago

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Dec 20, 2024, 3:35 PM EST - 4 weeks ago

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

Dec 20, 2024, 10:12 AM EST - 4 weeks ago

Cramer's Mad Dash: Vertex Pharmaceuticals

Dec 20, 2024, 8:45 AM EST - 4 weeks ago

Vertex Pharmaceuticals Inc. (VRTX) Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation

Dec 19, 2024, 2:11 PM EST - 4 weeks ago

Stocks on the Move: Vertex Pharma, Shake Shack, Zoom, Lennar and Home Depot

HD LEN SHAK ZM

Dec 19, 2024, 1:06 PM EST - 4 weeks ago

Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?

Dec 19, 2024, 10:50 AM EST - 4 weeks ago

Vertex Pharmaceuticals Inc. (VRTX) Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Dec 19, 2024, 10:31 AM EST - 4 weeks ago

Vertex Pharmaceuticals Stock Dives After Mixed Drug Study Results

Dec 19, 2024, 10:17 AM EST - 4 weeks ago

Cramer's Stop Trading: Vertex Pharmaceuticals

Dec 19, 2024, 6:00 AM EST - 4 weeks ago

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Dec 11, 2024, 11:56 AM EST - 5 weeks ago

Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy

Dec 9, 2024, 1:23 PM EST - 5 weeks ago

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

Dec 8, 2024, 12:52 PM EST - 5 weeks ago

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

Nov 29, 2024, 1:00 PM EST - 7 weeks ago

Undercovered Dozen: Arqit Quantum, CleanSpark, Sezzle, STAG Industrial +

CLSK STAG AES AGX AMZN ARQQ CXDO

Nov 25, 2024, 10:53 AM EST - 7 weeks ago

Vertex Pharma: Why I Am Buying This Dip

Nov 20, 2024, 3:06 PM EST - 2 months ago

Buy Signal Flashing For Struggling Biotech

Nov 19, 2024, 10:26 AM EST - 2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)

Nov 15, 2024, 2:28 PM EST - 2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 5, 2024, 4:13 PM EST - 2 months ago

Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It

Nov 4, 2024, 8:42 PM EST - 2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:04 PM EST - 2 months ago

Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength

Nov 4, 2024, 4:01 PM EST - 2 months ago

Vertex Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 4:05 PM EDT - 2 months ago

Vertex to Participate in Upcoming November Investor Conferences

Oct 25, 2024, 1:00 PM EDT - 3 months ago

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress

Oct 21, 2024, 3:23 AM EDT - 3 months ago

Vertex Pharmaceuticals: A Long-Term Growth Monster